.: "arise: a phase 3 randomized trial of erenumab for episodic migraine.".
.
treatment delays are also causing needless anxiety and distress to patients as well as putting lives at serious risk..
copyright © the asahi shimbun company. all rights reserved. no reproduction or republication without written permission.